UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.530

Sortiert nach

Small-cell lung cancer: what we know, what we need to know and the path forward

Nature reviews. Cancer, 2017-12, Vol.17 (12), p.725

2017

Link zum Volltext

Verfügbarkeit prüfen

Mechanical regulation of glycolysis via cytoskeleton architecture

Nature (London), 2020-02, Vol.578 (7796), p.621-626

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery

PloS one, 2009-07, Vol.4 (7), p.e6146-e6146

2009

Link zum Volltext

Verfügbarkeit prüfen

ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs

Cell reports (Cambridge), 2016-08, Vol.16 (5), p.1259-1272

2016

Link zum Volltext

Verfügbarkeit prüfen

Lung Cancer Computational Biology and Resources

Cold Spring Harbor perspectives in biology, 2022-02, Vol.12 (2), p.a038273

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular Biology of Lung Cancer: Clinical Implications

Clinics in chest medicine, 2011-12, Vol.32 (4), p.703-740

2011

Link zum Volltext

Verfügbarkeit prüfen

A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients

Clinical cancer research, 2013-03, Vol.19 (6), p.1577-1586

2013

Link zum Volltext

Verfügbarkeit prüfen

ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time

Cancer cell, 2010-12, Vol.18 (6), p.548-551

2010

Link zum Volltext

Verfügbarkeit prüfen

Small cell lung cancer: will recent progress lead to improved outcomes?

Clinical cancer research, 2015-05, Vol.21 (10), p.2244-2255

2015

Link zum Volltext

Verfügbarkeit prüfen

AP-1 leads the way in lung cancer transformation

Developmental cell, 2022-02, Vol.57 (3), p.292-294

2022

Link zum Volltext

Verfügbarkeit prüfen

Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer

Clinical cancer research, 2013-11, Vol.19 (22), p.6322-6328

2013

Link zum Volltext

Verfügbarkeit prüfen

Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis

Cell reports (Cambridge), 2016-08, Vol.16 (6), p.1614-1628

2016

Link zum Volltext

Verfügbarkeit prüfen

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer

The Journal of clinical investigation, 2016-09, Vol.126 (9), p.3219-3235

2016

Link zum Volltext

Verfügbarkeit prüfen

Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data

Nature reviews. Cancer, 2019-05, Vol.19 (5), p.289

2019

Link zum Volltext

Verfügbarkeit prüfen

Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment

Human mutation, 2014-06, Vol.35 (6), p.756-765

2014

Link zum Volltext

Verfügbarkeit prüfen

LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS -Mutant Lung Adenocarcinoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13), p.3251-3267

2019

Link zum Volltext

Verfügbarkeit prüfen

NRF2 regulates serine biosynthesis in non-small cell lung cancer

Nature genetics, 2015-12, Vol.47 (12), p.1475-1481

2015

Link zum Volltext

Verfügbarkeit prüfen

Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells

Molecular cell, 2019-12, Vol.76 (5), p.838-851.e5

2019

Link zum Volltext

Verfügbarkeit prüfen

Proteomics: A new dimension to decode small cell lung cancer

Cell, 2024-01, Vol.187 (1), p.14-16

2024

Link zum Volltext

Verfügbarkeit prüfen

miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers

PloS one, 2012-06, Vol.7 (6), p.e39167-e39167

2012

Link zum Volltext

Verfügbarkeit prüfen

CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells

Nature (London), 2017-06, Vol.546 (7656), p.168-172

2017

Link zum Volltext

Verfügbarkeit prüfen

Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells

PloS one, 2009-10, Vol.4 (10), p.e7464-e7464

2009

Link zum Volltext

Verfügbarkeit prüfen

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

Journal of thoracic oncology, 2015-05, Vol.10 (5), p.768-777

2015

Link zum Volltext

Verfügbarkeit prüfen

Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions

JNCI : Journal of the National Cancer Institute, 2017-01, Vol.109 (7), p.djw295

2017

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy

The lancet respiratory medicine, 2018-06, Vol.6 (6), p.472-478

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.530

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.461)
Mit Volltextzugriff
(1.456)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.518)
Japanisch
(286)
Schwedisch
(7)
Russisch
(4)
Deutsch
(2)
Norwegisch
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(966)
Humans
(856)
Life Sciences & Biomedicine
(782)
Oncology
(489)
Lung Neoplasms - Genetics
(327)
Female
(321)
Biological And Medical Sciences
(310)
Lung Cancer
(271)
Tumors
(264)
Male
(261)
Medical Sciences
(259)
Animals
(237)
Lung Neoplasms - Pathology
(214)
Mutation
(196)
Cell Line, Tumor
(193)
Carcinoma, Non-Small-Cell Lung - Genetics
(183)
Middle Aged
(167)
Mice
(165)
Science & Technology - Other Topics
(165)
Multidisciplinary Sciences
(164)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(277)
Plos One
(93)
Clinical Cancer Research
(64)
Oncogene
(58)
Proceedings Of The National Academy Of Sciences - Pnas
(42)
Journal Of Thoracic Oncology
(38)
Jnci : Journal Of The National Cancer Institute
(37)
Lung Cancer
(28)
Journal Of Clinical Oncology
(22)
Cancer Cell
(20)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Small-cell lung cancer: what we know, what we need to know and the path forward

Mechanical regulation of glycolysis via cytoskeleton architecture

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery

ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs

Lung Cancer Computational Biology and Resources

Molecular Biology of Lung Cancer: Clinical Implications

A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients

ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time

Small cell lung cancer: will recent progress lead to improved outcomes?

AP-1 leads the way in lung cancer transformation

Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer

Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer

Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data

Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment

LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS -Mutant Lung Adenocarcinoma

NRF2 regulates serine biosynthesis in non-small cell lung cancer

Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells

Proteomics: A new dimension to decode small cell lung cancer

miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers

CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells

Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions

Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy

Suchergebnisse filtern